What is MSACL?
MSACL is dedicated to bridging the gap between pre-clinical research and clinical patient care through the application of advanced mass spectrometry technologies. The company actively fosters knowledge exchange and professional development within the field via initiatives such as the MSACL 2025 conference, which includes workshops, educational grants, and abstract submission opportunities. Their offerings extend to specialized industry workshops and training courses, catering to professionals and researchers in clinical and laboratory environments seeking to enhance their expertise and practical application of mass spectrometry.
How much funding has MSACL raised?
MSACL has raised a total of $54K across 1 funding round:
Debt
$54K
Debt (2021): $54K with participation from PPP
What's next for MSACL?
With the recent influx of $54K in expansion capital, MSACL is poised for accelerated growth and innovation. This funding is expected to fuel the scaling of its operations, potentially enhancing its conference offerings, expanding its training programs, and further solidifying its position as a leader in translating mass spectrometry research into tangible clinical applications. The company's focus on knowledge dissemination and practical training suggests a strategic direction aimed at empowering the clinical laboratory sector with cutting-edge mass spectrometry solutions.
See full MSACL company page
